Dr. Richard A Poel, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7149 E 200 S, Huntsville, UT 84317 Phone: 801-745-9699 Fax: 801-745-3426 |
News Archive
C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP).
Neuroscientists at Stanford University School of Medicine have homed in on potential differences in autistic people's brain cells by studying brainlike spheres grown in an elaborate process from skin cells.
While biometric equipment is gaining popularity in a variety of applications, such as ensuring secure access to buildings, industries are finding that many users believe the devices are unsanitary and a potential source of germs that could cause illness.
Those who fear needles have good news awaiting them. Australian researchers have developed a new method of vaccine delivery using needle-free nano-patches. These could also be mailed to people during pandemics. This breakthrough is published in the latest edition of the journal Small.
Immunity gained after natural infection from the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is boosted when people take the first Pfizer-BioNTech vaccine, according to a new study led by Iain C. Chapple from the University of Birmingham.
› Verified 5 days ago